INmune Bio Inc expected to post a loss of 53 cents a share - Earnings Preview

Inmune Bio

30/04/2024 24:36

* INmune Bio Inc  INMB.OQ   INMB.O  is expected to report
resultson May 1 (estimated) for the period ending March 31 2024
    * The Boca Raton Florida-based  company is expected to
report
revenue of $30 thousand, according to the estimate from one
analyst, based on LSEG data.
    * ​LSEG's mean analyst estimate for INmune Bio Inc is for a
loss
of 53 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for INmune Bio
Inc is
$21.00​, above​ its last closing price of $11.77. ​​​

This summary was machine generated April 29 at 23:36 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)